The Role of PARP-1 and PARP-2 Enzymes in Metabolic Regulation and Disease

Circadian Control of the NAD ⁺ Salvage Pathway by CLOCK-SIRT1

Nakahata, Y., Sahar, S., Astarita, G., Kaluzova, M., & Sassone-Corsi, P. (2009) · Science · doi:10.1126/science.1170803 · Cited by 1,198 · see citing works

The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways

Houtkooper, R. H., Cantó, C., Wanders, R. J., & Auwerx, J. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0026 · Cited by 899 · see citing works

PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation

Bai, P., Cantó, C., Oudart, H., Brunyánszki, A., Cen, Y., Thomas, C., Yamamoto, H., Huber, A., Kiss, B., Houtkooper, R. H., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.03.004 · Cited by 837 · see citing works

The PARP Side of the Nucleus: Molecular Actions, Physiological Outcomes, and Clinical Targets

Krishnakumar, R., & Kraus, W. L. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.06.017 · Cited by 836 · see citing works

Mice lacking the poly(ADP-ribose) polymerase gene are resistant to pancreatic beta-cell destruction and diabetes development induced by streptozocin

Burkart, V., Wang, Z., Radons, J., Heller, B., Herceg, Z., Stingl, L., Wagner, E. F., & Kolb, H. (1999) · Nature Medicine · doi:10.1038/6535 · Cited by 371 · see citing works

Poly(ADP-ribose) polymerase 1 participates in the phase entrainment of circadian clocks to feeding

Asher, G., Reinke, H., Altmeyer, M., Gutierrez-Arcelus, M., Hottiger, M. O., & Schibler, U. (2010) · Cell · doi:10.1016/j.cell.2010.08.016 · Cited by 340 · see citing works

SIRT1 Promotes Cell Survival under Stress by Deacetylation-Dependent Deactivation of Poly(ADP-Ribose) Polymerase 1

Rajamohan, S. B., Pillai, V. B., Gupta, M., Sundaresan, N. R., Birukov, K. G., Samant, S. A., Hottiger, M. O., & Gupta, M. P. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00121-09 · Cited by 303 · see citing works

PARP-2 Regulates SIRT1 Expression and Whole-Body Energy Expenditure

Bai, P., Cantó, C., Brunyánszki, A., Huber, A., Szántó, M., Cen, Y., Yamamoto, H., Houten, S. M., Kiss, B., Oudart, H., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.03.013 · Cited by 250 · see citing works

Amelioration of Diabetes Mellitus in Partially Depancreatized Rats by Poly(ADP-ribose) Synthetase Inhibitors: Evidence of Islet B-Cell Regeneration

Yonemura, Y., Takashima, T., Miwa, K., Miyazaki, I., Yamamoto, H., & Okamoto, H. (1984) · Diabetes · doi:10.2337/diab.33.4.401 · Cited by 170 · see citing works

Tricarboxylic Acid Cycle Substrates Prevent PARP-Mediated Death of Neurons and Astrocytes

Ying, W., Chen, Y., Alano, C. C., & Swanson, R. A. (2002) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200207000-00002 · Cited by 130 · see citing works

Identification of poly‐ADP‐ribosylated mitochondrial proteins after traumatic brain injury

Lai, Y., Chen, Y., Watkins, S. C., Nathaniel, P. D., Guo, F., Kochanek, P. M., Jenkins, L. W., Szabó, C., & Clark, R. S. B. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05114.x · Cited by 110 · see citing works

Peroxisome Proliferator-activated Receptor (PPAR)-2 Controls Adipocyte Differentiation and Adipose Tissue Function through the Regulation of the Activity of the Retinoid X Receptor/PPARγ Heterodimer

Bai, P., Houten, S. M., Huber, A., Schreiber, V., 渡辺, 光., Kiss, B., de MURCIA, G., Auwerx, J. H., & Murcia, J. M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701021200 · Cited by 104 · see citing works

Functional Localization of Two Poly(ADP-Ribose)-Degrading Enzymes to the Mitochondrial Matrix

Niere, M., Kernstock, S., Koch‐Nolte, F., & Ziegler, M. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01766-07 · Cited by 101 · see citing works

Poly(ADP-Ribose)Polymerase-1 (PARP1) Controls Adipogenic Gene Expression and Adipocyte Function

Erener, S., Hesse, M., Kostadinova, R. M., & Hottiger, M. O. (2011) · Molecular Endocrinology · doi:10.1210/me.2011-1163 · Cited by 75 · see citing works

Inflammatory and age-related pathologies in mice with ectopic expression of human PARP-1

Mangerich, A., Herbach, N., Hanf, B., Fischbach, A., Popp, O., Moreno‐Villanueva, M., Bruns†, O. T., & Bürkle, A. (2010) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2010.05.005 · Cited by 66 · see citing works

Regulation of FOXO1-mediated transcription and cell proliferation by PARP-1

Sakamaki, J.-I., Daitoku, H., Yoshimochi, K., Miwa, M., & Fukamizu, A. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.03.022 · Cited by 65 · see citing works

PARP1 deficiency exacerbates diet-induced obesity in mice

Devalaraja-Narashimha, K. B., & Padanilam, B. J. (2010) · Journal of Endocrinology · doi:10.1677/joe-09-0402 · Cited by 64 · see citing works

<i>ARTD1</i> deletion causes increased hepatic lipid accumulation in mice fed a high‐fat diet and impairs adipocyte function and differentiation

Erener, S., Mirsaidi, A., Hesse, M., Tiaden, A. N., Ellingsgaard, H., Kostadinova, R., Donath, M. Y., Richards, P. J., & Hottiger, M. O. (2012) · The FASEB Journal · doi:10.1096/fj.11-200212 · Cited by 48 · see citing works

The hypoxic preconditioning agent deferoxamine induces poly(ADP-ribose) polymerase-1-dependent inhibition of the mitochondrial respiratory chain

Cañuelo, A., Martínez‐Romero, R., Martínez‐Lara, E., Sánchez-Alcázar, J. A., & Siles, E. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-1162-1 · Cited by 13 · see citing works

NAD+ Metabolism and the Control of Energy Homeostasis: A Balancing Act between Mitochondria and the Nucleus

Cantó, C., Menzies, K. J., & Auwerx, J. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.05.023 · Cited by 1,648 · see citing works

NAD+ metabolism and its roles in cellular processes during ageing

Covarrubias, A. J., Perrone, R., Grozio, A., & Verdin, E. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00313-x · Cited by 1,617 · see citing works

NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential

Xie, N., Zhang, L., Gao, W. Q., Huang, C., Huber, P., Zhou, X., Li, C. L., Shen, G., & Zou, B. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00311-7 · Cited by 1,078 · see citing works

CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism

Camacho-Pereira, J., Tarragó, M. G., Chini, C. C. S., Nin, V., Escande, C., Warner, G. M., Puranik, A. S., Schoon, R. A., Reid, J. M., Galina, A., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.05.006 · Cited by 901 · see citing works

Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence

Rajman, L., Chwalek, K., & Sinclair, D. A. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.02.011 · Cited by 865 · see citing works

The role of oxidative stress during inflammatory processes

Lugrin, J., Rosenblatt‐Velin, N., Parapanov, R., & Liaudet, L. (2013) · Biological Chemistry · doi:10.1515/hsz-2013-0241 · Cited by 742 · see citing works

NAD+ homeostasis in health and disease

Katsyuba, E., Romani, M., Hofer, D., & Auwerx, J. (2020) · Nature Metabolism · doi:10.1038/s42255-019-0161-5 · Cited by 627 · see citing works

Poly(ADP-ribose) polymerase inhibition: past, present and future

Curtin, N. J., & Szabó, C. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0076-6 · Cited by 576 · see citing works

Understanding and overcoming resistance to PARP inhibitors in cancer therapy

Dias, M. P., Moser, S. C., Ganesan, S., & Jonkers, J. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00532-x · Cited by 526 · see citing works

The evolving metabolic landscape of chromatin biology and epigenetics

Dai, Z., Ramesh, V., & Locasale, J. W. (2020) · Nature Reviews Genetics · doi:10.1038/s41576-020-0270-8 · Cited by 494 · see citing works

Regulation of chromatin and gene expression by metabolic enzymes and metabolites

Li, X., Egervári, G., Wang, Y., Berger, S. L., & Lu, Z. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0029-7 · Cited by 486 · see citing works

Biology of Poly(ADP-Ribose) Polymerases: The Factotums of Cell Maintenance

Bai, P. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.01.034 · Cited by 445 · see citing works

A Potent and Specific CD38 Inhibitor Ameliorates Age-Related Metabolic Dysfunction by Reversing Tissue NAD+ Decline

Tarragó, M. G., Chini, C. C. S., Kanamori, K. S., Warner, G. M., Caride, A., de Oliveira, G. C., Rud, M., Samani, A., Hein, K. Z., Huang, R., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.03.016 · Cited by 384 · see citing works

PARP inhibition promotes ferroptosis via repressing SLC7A11 and synergizes with ferroptosis inducers in BRCA-proficient ovarian cancer

Hong, T., Lei, G., Chen, X., Li, H., Zhang, X., Wu, N., Zhao, Y., Zhang, Y., & Wang, J. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101928 · Cited by 381 · see citing works

Poly (ADP-Ribose) Polymerase Inhibitors: Recent Advances and Future Development

Scott, C. L., Swisher, E. M., & Kaufmann, S. H. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.58.8848 · Cited by 356 · see citing works

Molecular mechanisms of aging and anti-aging strategies

Li, Y., Tian, X., Luo, J., Bao, T., Wang, S., & Wu, X. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01663-1 · Cited by 333 · see citing works

Interplay of oxidative, nitrosative/nitrative stress, inflammation, cell death and autophagy in diabetic cardiomyopathy

Varga, Z. V., Giricz, Z., Liaudet, L., Haskó, G., Ferdinandy, P., & Pacher, P. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.06.030 · Cited by 286 · see citing works

Sirtuins: guardians of mammalian healthspan

Giblin, W., Skinner, M. E., & Lombard, D. B. (2014) · Trends in Genetics · doi:10.1016/j.tig.2014.04.007 · Cited by 280 · see citing works

SIRT7 promotes genome integrity and modulates non‐homologous end joining DNA repair

Vázquez, B. N., Thackray, J. K., Simonet, N. G., Kane‐Goldsmith, N., Martínez‐Redondo, P., Nguyen, T. T. T., Bunting, S. F., Vaquero, A., Tischfield, J. A., & Serrano, L. (2016) · The EMBO Journal · doi:10.15252/embj.201593499 · Cited by 267 · see citing works

PARP-1 and gene regulation: Progress and puzzles

Kraus, W. L., & Hottiger, M. O. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2013.01.005 · Cited by 255 · see citing works

Pharmacological Inhibition of poly(ADP-ribose) polymerases improves fitness and mitochondrial function in skeletal muscle

Pirinen, E., Cantó, C., Jo, Y. S., Morato, L., Zhang, H., Menzies, K. J., Williams, E. G., Mouchiroud, L., Moullan, N., Hagberg, C., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.04.002 · Cited by 254 · see citing works

Crosstalk between poly(ADP-ribose) polymerase and sirtuin enzymes

Cantó, C., Sauve, A. A., & Bai, P. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2013.01.004 · Cited by 246 · see citing works

NAD+ homeostasis in human health and disease

Perez, R. Z., Wanders, R. J. A., van Karnebeek, C., & Houtkooper, R. H. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.202113943 · Cited by 238 · see citing works

PARP-1 involvement in neurodegeneration: A focus on Alzheimer’s and Parkinson’s diseases

Martire, S., Mosca, L., & D’Erme, M. (2015) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2015.04.001 · Cited by 228 · see citing works

Modulating NAD+ metabolism, from bench to bedside

Katsyuba, E., & Auwerx, J. H. (2017) · The EMBO Journal · doi:10.15252/embj.201797135 · Cited by 224 · see citing works

Proteome-wide identification of the endogenous ADP-ribosylome of mammalian cells and tissue

Martello, R., Leutert, M., Jungmichel, S., Bilan, V., Buch-Larsen, S. C., Young, C., Hottiger, M. O., & Nielsen, M. L. (2016) · Nature Communications · doi:10.1038/ncomms12917 · Cited by 214 · see citing works

Cytotoxicity and genotoxicity of nano - and microparticulate copper oxide: role of solubility and intracellular bioavailability

Semisch, A., Ohle, J., Witt, B., & Hartwig, A. (2014) · Particle and Fibre Toxicology · doi:10.1186/1743-8977-11-10 · Cited by 203 · see citing works

Identification of a Common Non-Apoptotic Cell Death Mechanism in Hereditary Retinal Degeneration

Arango‐González, B., Trifunović, D., Sahaboglu, A., Kranz, K., Michalakis, S., Farinelli, P., Koch, S., Koch, F., Cottet, S., Janssen‐Bienhold, U., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112142 · Cited by 209 · see citing works

Relevance of SIRT1-NF-κB Axis as Therapeutic Target to Ameliorate Inflammation in Liver Disease

de Gregorio, E., Colell, A., Morales, A., & Marı́, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113858 · Cited by 202 · see citing works

PARPs and ADP-Ribosylation: 50 Years … and Counting

Kraus, W. L. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.06.006 · Cited by 191 · see citing works

Integrating cellular senescence with the concept of damage accumulation in aging: Relevance for clearance of senescent cells

Ogrodnik, M., Salmonowicz, H., & Gladyshev, V. N. (2019) · Aging Cell · doi:10.1111/acel.12841 · Cited by 184 · see citing works

Telomere Dysfunction Induces Sirtuin Repression that Drives Telomere-Dependent Disease

Amano, H., Chaudhury, A., Rodriguez-Aguayo, C., Lu, L., Akhanov, V., Catic, A., Popov, Y. V., Verdin, E., Johnson, H., Stossi, F., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.03.001 · Cited by 182 · see citing works

Distribution of protein poly(ADP-ribosyl)ation systems across all domains of life

Perina, D., Mikoč, A., Ahel, J., Ćetković, H., Žaja, R., & Ahel, I. (2014) · DNA repair · doi:10.1016/j.dnarep.2014.05.003 · Cited by 186 · see citing works

PARPs in lipid metabolism and related diseases

Szántó, M., Gupte, R., Kraus, W. L., Pacher, P., & Bai, P. (2021) · Progress in Lipid Research · doi:10.1016/j.plipres.2021.101117 · Cited by 184 · see citing works

The role of PARP1 in neurodegenerative diseases and aging

Mao, K., & Zhang, G. (2022) · The FEBS Journal · doi:10.1111/febs.15716 · Cited by 172 · see citing works

Inhibiting poly ADP-ribosylation increases fatty acid oxidation and protects against fatty liver disease

Gariani, K., Ryu, D., Menzies, K. J., Yi, H.-S., Stein, S., Zhang, H., Perino, A., Lemos, V., Katsyuba, E., Jha, P., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.08.024 · Cited by 167 · see citing works

Delivering widespread BRCA testing and PARP inhibition to patients with ovarian cancer

George, A., Kaye, S., & Banerjee, S. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.191 · Cited by 158 · see citing works

RNA polymerase III is required for the repair of DNA double-strand breaks by homologous recombination

Liu, S., Yu, H., Wang, J., Li, L., Yuan, J., Zhang, B., Wang, Z., Ji, J., & Kong, D. (2021) · Cell · doi:10.1016/j.cell.2021.01.048 · Cited by 156 · see citing works

Spatiotemporal compartmentalization of hepatic NADH and NADPH metabolism

Goodman, R. P., Calvo, S. E., & Mootha, V. K. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.tm117.000258 · Cited by 148 · see citing works

A new wave of innovations within the DNA damage response

Li, Q., Qian, W., Zhang, Y., Hu, L., Chen, S., & Xia, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01548-8 · Cited by 152 · see citing works

Evidence for a Direct Effect of the NAD+ Precursor Acipimox on Muscle Mitochondrial Function in Humans

van de Weijer, T., Phielix, E., Bilet, L., Williams, E. G., Ropelle, E. R., Bierwagen, A., Livingstone, R., Nowotny, P., Sparks, L. M., Paglialunga, S., et al. (2015) · Diabetes · doi:10.2337/db14-0667 · Cited by 139 · see citing works

Medicinal chemistry approaches of poly ADP-Ribose polymerase 1 (PARP1) inhibitors as anticancer agents - A recent update

Jain, P. G., & Patel, B. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.01.024 · Cited by 141 · see citing works

Non‐coding RNAs: the dark side of nuclear–mitochondrial communication

Vendramin, R., Marine, J., & Leucci, E. (2017) · The EMBO Journal · doi:10.15252/embj.201695546 · Cited by 123 · see citing works

PARP Power: A Structural Perspective on PARP1, PARP2, and PARP3 in DNA Damage Repair and Nucleosome Remodelling

van Beek, L., McClay, É., Patel, S., Schimpl, M., Spagnolo, L., & de Oliveira, T. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105112 · Cited by 128 · see citing works

SIRT1 metabolic actions: Integrating recent advances from mouse models

Boutant, M., & Cantó, C. (2013) · Molecular Metabolism · doi:10.1016/j.molmet.2013.10.006 · Cited by 121 · see citing works

Poly(ADP-ribose) polymerases as modulators of mitochondrial activity

Bai, P., Nagy, L., Fodor, T., Liaudet, L., & Pacher, P. (2014) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2014.11.003 · Cited by 119 · see citing works

Predictive biomarkers for cancer therapy with PARP inhibitors

Michels, J., Vitale, I., Saparbaev, M. K., Castedo, M., & Kroemer, G. (2013) · Oncogene · doi:10.1038/onc.2013.352 · Cited by 113 · see citing works

The Elephant and the Blind Men: Making Sense of PARP Inhibitors in Homologous Recombination Deficient Tumor Cells

Lorenzo, S. B. D., Patel, A. G., Hurley, R. M., & Kaufmann, S. H. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00228 · Cited by 110 · see citing works

Poly(ADP-ribose): A signaling molecule in different paradigms of cell death

Aredia, F., & Scovassi, A. I. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.06.021 · Cited by 108 · see citing works

ADP-ribosylation signalling and human disease

Palazzo, L., Mikolčević, P., Mikoč, A., & Ahel, I. (2019) · Open Biology · doi:10.1098/rsob.190041 · Cited by 104 · see citing works

Adipose tissue NAD+-homeostasis, sirtuins and poly(ADP-ribose) polymerases -important players in mitochondrial metabolism and metabolic health

Jokinen, R., Pirnes-Karhu, S., Pietiläinen, K. H., & Pirinen, E. (2017) · Redox Biology · doi:10.1016/j.redox.2017.02.011 · Cited by 103 · see citing works

Role of poly(ADP‐ribose) polymerases in the regulation of inflammatory processes

Bai, P., & Virág, L. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.09.026 · Cited by 101 · see citing works

Poly(ADP‐ribose) Polymerase 1 (PARP1) in Atherosclerosis: From Molecular Mechanisms to Therapeutic Implications

Xu, S., Bai, P., Little, P. J., & Liu, P. (2013) · Medicinal Research Reviews · doi:10.1002/med.21300 · Cited by 97 · see citing works

Accurate Measurement of Nicotinamide Adenine Dinucleotide (NAD+) with High-Performance Liquid Chromatography

Yoshino, J., & Imai, S. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-637-5_14 · Cited by 95 · see citing works

Enhancing NAD+ salvage pathway reverts the toxicity of primary astrocytes expressing amyotrophic lateral sclerosis-linked mutant superoxide dismutase 1 (SOD1)

Harlan, B. A., Pehar, M., Sharma, D. R., Beeson, G., Beeson, C. C., & Vargas, M. R. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.698779 · Cited by 94 · see citing works

Efficacy and tolerability of EH301 for amyotrophic lateral sclerosis: a randomized, double-blind, placebo-controlled human pilot study

de la Rubia, J. E., Drehmer, E., Platero, J. L., Benlloch, M., Caplliure-Llopis, J., Villaron-Casales, C., de Bernardo, N., AlarcÓn, J., Fuente, C., Carrera, S., et al. (2019) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2018.1536152 · Cited by 92 · see citing works

Pivotal role of NAMPT in the switch of melanoma cells toward an invasive and drug-resistant phenotypePreprint

Ohanna, M., Cerezo, M., Nottet, N., Bille, K., Didier, R., Béranger, G. E., Mograbi, B., Rocchi, S., Yvan‐Charvet, L., Ballotti, R., et al. (2018) · Genes & Development · doi:10.1101/gad.305854.117 · Cited by 91 · see citing works

Puerarin protects against high‐fat high‐sucrose diet‐induced non‐alcoholic fatty liver disease by modulating PARP‐1/PI3K/AKT signaling pathway and facilitating mitochondrial homeostasis

Wang, S., Yang, F., Shang, L., Zhang, Y., Zhou, Y., & Shi, X. (2019) · Phytotherapy Research · doi:10.1002/ptr.6417 · Cited by 91 · see citing works

The role of ADP-ribose metabolism in metabolic regulation, adipose tissue differentiation, and metabolismPreprint

Szántó, M., & Bai, P. (2020) · Genes & Development · doi:10.1101/gad.334284.119 · Cited by 88 · see citing works

Critical Role of ADAMTS-4 in the Development of Sporadic Aortic Aneurysm and Dissection in Mice

Ren, P., Hughes, M. S., Krishnamoorthy, S., Zou, S., Zhang, L., Wu, D., Zhang, C., Curci, J. A., Coselli, J. S., Milewicz, D. M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-12248-z · Cited by 80 · see citing works

Nicotinamide adenine dinucleotide: Biosynthesis, consumption and therapeutic role in cardiac diseases

Tannous, C., Booz, G. W., Altara, R., Muhieddine, D. H., Mericskay, M., Refaat, M. M., & Zouein, F. A. (2020) · Acta Physiologica · doi:10.1111/apha.13551 · Cited by 79 · see citing works

Loss of the Mono-ADP-ribosyltransferase, Tiparp, Increases Sensitivity to Dioxin-induced Steatohepatitis and Lethality

Ahmed, S., Bott, D., Gomez, A. V., Tamblyn, L., Rasheed, A., Cho, T., MacPherson, L., Sugamori, K. S., Yang, Y., Grant, D. M., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.660100 · Cited by 79 · see citing works

PARP inhibitors: polypharmacology versus selective inhibition

Ekblad, T., Camaioni, E., Schuler, H., & Macchiarulo, A. (2013) · FEBS Journal · doi:10.1111/febs.12298 · Cited by 78 · see citing works

Genome-Wide Profiling of PARP1 Reveals an Interplay with Gene Regulatory Regions and DNA Methylation

Nalabothula, N., Al-jumaily, T., Eteleeb, A. M., Flight, R. M., Shao, X., Moseley, H., Rouchka, E. C., & Fondufe‐Mittendorf, Y. N. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135410 · Cited by 77 · see citing works

Nicotinamide Adenine Dinucleotide Metabolism and Neurodegeneration

Pehar, M., Harlan, B. A., Killoy, K. M., & Vargas, M. R. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7145 · Cited by 77 · see citing works

Acetylation promotes TyrRS nuclear translocation to prevent oxidative damage

Cao, X., Li, C., Xiao, S., Tang, Y., Huang, J., Zhao, S., Li, X., Li, J., Zhang, R., & Yu, W. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1608488114 · Cited by 75 · see citing works

Inborn disorders of the malate aspartate shuttle

Broeks, M. H., van Karnebeek, C., Wanders, R. J. A., Jans, J. J. M., & Verhoeven‐Duif, N. M. (2021) · Journal of Inherited Metabolic Disease · doi:10.1002/jimd.12402 · Cited by 75 · see citing works

Puerarin protects against CCl4-induced liver fibrosis in mice: possible role of PARP-1 inhibition

Wang, S., Shi, X., Feng, M., Wang, X., Zhang, Z., Zhao, X., Han, B., Ma, H., Dai, B., & Ding, Y.-T. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.06.008 · Cited by 76 · see citing works

NAD+ Homeostasis and NAD+-Consuming Enzymes: Implications for Vascular Health

Campagna, R., & Vignini, A. (2023) · Antioxidants · doi:10.3390/antiox12020376 · Cited by 74 · see citing works

Deficiency of Parkinson’s disease-related gene Fbxo7 is associated with impaired mitochondrial metabolism by PARP activation

Delgado-Camprubi, M., Esteras, N., Soutar, M. P., Plun-Favreau, H., & Abramov, A. Y. (2017) · Cell Death &amp; Differentiation · doi:10.1038/cdd.2016.104 · Cited by 71 · see citing works

MicroRNA-379-5p is associated with biochemical premature ovarian insufficiency through PARP1 and XRCC6

Dang, Y., Wang, X., Hao, Y., Zhang, X., Zhao, S., Ma, J., Qin, Y., & Chen, Z. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0163-8 · Cited by 66 · see citing works

PARPs in genome stability and signal transduction: implications for cancer therapy

Palazzo, L., & Ahel, I. (2018) · Biochemical Society Transactions · doi:10.1042/bst20180418 · Cited by 70 · see citing works

Radioresistance of Brain Tumors

Kelley, K. D., Knisely, J. P. S., Symons, M. H., & Ruggieri, R. (2016) · Cancers · doi:10.3390/cancers8040042 · Cited by 64 · see citing works

In-silico Design, ADMET Screening, MM-GBSA Binding Free Energy of Some Novel Isoxazole Substituted 9-Anilinoacridines as HER2 Inhibitors Targeting Breast Cancer

Rajagopal, K., Pandiselvi, A., Byran, G., & Balachandran, P. (2019) · Current Drug Research Reviews · doi:10.2174/2589977511666190912154817 · Cited by 64 · see citing works

Bi-allelic ADPRHL2 Mutations Cause Neurodegeneration with Developmental Delay, Ataxia, and Axonal Neuropathy

Danhauser, K., Alhaddad, B., Makowski, C. C., Piekutowska‐Abramczuk, D., Syrbe, S., Gomez‐Ospina, N., Manning, M. A., Kostera‐Pruszczyk, A., Krahn-Peper, C., Berutti, R., et al. (2018) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2018.10.005 · Cited by 64 · see citing works

Bioenergetic Impairment in Animal and Cellular Models of Alzheimer’s Disease: PARP-1 Inhibition Rescues Metabolic Dysfunctions

Martire, S., Fuso, A., Mosca, L., Forte, E., Correani, V., Fontana, M., Scarpa, S., Maras, B., & D’Erme, M. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-151040 · Cited by 62 · see citing works

SIRT1-metabolite binding histone macroH2A1.1 protects hepatocytes against lipid accumulation

Pazienza, V., Borghesan, M., Mazza, T., Sheedfar, F., Panebianco, C., Williams, R. L., Mazzoccoli, G., Andriulli, A., Nakanishi, T., & Vinciguerra, M. (2014) · Aging · doi:10.18632/aging.100632 · Cited by 61 · see citing works

TCDD-inducible poly-ADP-ribose polymerase (TIPARP/PARP7) mono-ADP-ribosylates and co-activates liver X receptors

Bindesbøll, C., Tan, S., Bott, D., Cho, T., Tamblyn, L., MacPherson, L., Grønning-Wang, L. M., Nebb, H. I., & Matthews, J. B. (2016) · Biochemical Journal · doi:10.1042/bj20151077 · Cited by 59 · see citing works

Poly(ADP-Ribose) Polymerases in Host-Pathogen Interactions, Inflammation, and Immunity

Brady, P. N., Goel, A., & Johnson, M. A. (2019) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00038-18 · Cited by 58 · see citing works

Detection of cerebral NAD+ by in vivo1H NMR spectroscopy

de Graaf, R. A., & Behar, K. L. (2014) · NMR in Biomedicine · doi:10.1002/nbm.3121 · Cited by 57 · see citing works

NAD+ and NAFLD – caution, causality and careful optimism

Dall, M., Hassing, A. S., & Treebak, J. T. (2021) · The Journal of Physiology · doi:10.1113/jp280908 · Cited by 57 · see citing works

Liquid-liquid phase separation in DNA double-strand breaks repair

Wang, Y., Zhao, W.-W., Shi, J., Wan, X., Zheng, J., & Fan, X. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06267-0 · Cited by 59 · see citing works

Impact of NAD+ metabolism on ovarian aging

Liang, J., Huang, F., Song, Z., Tang, R., Zhang, P., & Chen, R. (2023) · Immunity & Ageing · doi:10.1186/s12979-023-00398-w · Cited by 56 · see citing works

Age- and AD-related redox state of NADH in subcellular compartments by fluorescence lifetime imaging microscopy

Dong, Y., Digman, M. A., & Brewer, G. J. (2019) · GeroScience · doi:10.1007/s11357-019-00052-8 · Cited by 54 · see citing works

The secret messages between mitochondria and nucleus in muscle cell biology

Soledad, R. B., Charles, S., & Das, S. (2019) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2019.03.019 · Cited by 53 · see citing works

Role of PARP-1 in mitochondrial homeostasis

Kadam, A. A., Jubin, T., Roychowdhury, R., & Begum, R. (2020) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2020.129669 · Cited by 55 · see citing works

NAD+ metabolism-based immunoregulation and therapeutic potential

Fang, J., Chen, W., Hou, P., Liu, Z., Zuo, M., Liu, S., Feng, C., Han, Y., Li, P., Shi, Y., et al. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01031-5 · Cited by 54 · see citing works

PARP-1 inhibition ameliorates elastase induced lung inflammation and emphysema in mice

Dharwal, V., & Naura, A. S. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.01.027 · Cited by 53 · see citing works

ARTD1-induced poly-ADP-ribose formation enhances PPARγ ligand binding and co-factor exchange

Lehmann, M., Pirinen, E., Mirsaidi, A., Kunze, F. A., Richards, P. J., Auwerx, J. H., & Hottiger, M. O. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku1260 · Cited by 52 · see citing works

Bioorthogonally Functionalized NAD+ Analogues for In‐Cell Visualization of Poly(ADP‐Ribose) Formation

Schlesiger, S., Buntz, A., Wang, Y., Zumbusch, A., & Marx, A. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201600464 · Cited by 52 · see citing works

The Central Role of the NAD+ Molecule in the Development of Aging and the Prevention of Chronic Age-Related Diseases: Strategies for NAD+ Modulation

Poljšak, B., Kovač, V., Špalj, S., & Milisav, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032959 · Cited by 58 · see citing works

Glucose availability controls adipogenesis in mouse 3T3-L1 adipocytes via up-regulation of nicotinamide metabolism

Jackson, R. M., Griesel, B. A., Gurley, J. M., Szweda, L. I., & Olson, A. L. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.791970 · Cited by 52 · see citing works

Downregulation of PARP1 transcription by CDK4/6 inhibitors sensitizes human lung cancer cells to anticancer drug-induced death by impairing OGG1-dependent base excision repair

Tempka, D., Tokarz, P., Chmielewska, K., Kluska, M., Pietrzak, J., Rygielska, Z., Virág, L., & Robaszkiewicz, A. (2017) · Redox Biology · doi:10.1016/j.redox.2017.12.017 · Cited by 50 · see citing works

Poly (ADP-ribose) in the pathogenesis of Parkinson's disease

Lee, Y., Kang, H. C., Lee, B. D., Lee, Y.-I., Kim, Y. P., & Shin, J. (2014) · BMB Reports · doi:10.5483/bmbrep.2014.47.8.119 · Cited by 50 · see citing works

Regulation of the redox metabolome and thiol proteome by hydrogen sulfide

Kumar, R., & Banerjee, R. V. (2021) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2021.1893641 · Cited by 46 · see citing works

A Double-Edged Sword: The Two Faces of PARylation

Kang, M., Park, S., Park, S., Lee, H. G., & Park, J. H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179826 · Cited by 46 · see citing works

Hepatic DNA Damage Induced by Electronic Cigarette Exposure Is Associated With the Modulation of NAD+/PARP1/SIRT1 Axis

Espinoza‐Derout, J., Shao, X. M., Bankole, E., Hasan, K. M., Mtume, N., Liu, Y., Sinha‐Hikim, A. P., & Friedman, T. C. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00320 · Cited by 47 · see citing works

Targeting NAD+ degradation: The therapeutic potential of flavonoids for Alzheimer's disease and cognitive frailty

Ruan, Q., Ruan, J., Zhang, W., Qian, F., & Yu, Z. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.08.010 · Cited by 44 · see citing works

PARP Inhibitors and Myeloid Neoplasms: A Double-Edged Sword

Csizmar, C. M., Saliba, A. N., Swisher, E. M., & Kaufmann, S. H. (2021) · Cancers · doi:10.3390/cancers13246385 · Cited by 45 · see citing works

Metabolic roles of poly(ADP-ribose) polymerases

Vida, A., Márton, J., Mikó, E., & Bai, P. (2016) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2016.12.009 · Cited by 66 · see citing works

Methods to Assess the Role of PARPs in Regulating Mitochondrial Oxidative Function

Kovàcs, T., Rauch, B., Mikó, E., & Bai, P. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2891-1_14 · Cited by 4 · see citing works

Poly(ADP-ribose) polymerase-2: emerging transcriptional roles of a DNA-repair protein

Szántó, M., Brunyánszki, A., Kiss, B., Nagy, L., Gergely, P., Virág, L., & Bai, P. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1003-8 · Cited by 82 · see citing works

Poly(ADP-ribose) polymerases as modulators of mitochondrial activity

Bai, P., Nagy, L., Fodor, T., Liaudet, L., & Pacher, P. (2014) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2014.11.003 · Cited by 119 · see citing works

Biology of Poly(ADP-Ribose) Polymerases: The Factotums of Cell Maintenance

Bai, P. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.01.034 · Cited by 445 · see citing works